pentamidine has been researched along with adenosine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Caljon, G; Campagnaro, GD; de Koning, HP; Hulpia, F; Maes, L; Scortichini, M; Van Calenbergh, S; Van Hecke, K | 1 |
| Alfayez, IA; Bouton, J; Caljon, G; Campagnaro, GD; de Koning, HP; Hulpia, F; Mabille, D; Maes, L; Van Calenbergh, S | 1 |
| Berger, BJ; Carter, NS; Fairlamb, AH | 2 |
| Asiri, S; Ogbunude, PO; Warhurst, DC | 1 |
| Baltz, T; Barrett, MP; Denise, H; Giroud, C; Zhang, ZQ | 1 |
| Scott, AG; Tait, A; Turner, CM | 1 |
| Ballet, JJ; Brasseur, P; Delaunay, A; Favennec, L; Gargala, G | 1 |
| de Koning, HP; Jarvis, SM | 2 |
| Barrett, MP; Brun, R; Burchmore, RJ; de Koning, HP; Enyaru, JC; Geiser, F; Kaminsky, R; Mäser, P; Matovu, E; Seebeck, T; Stewart, ML; Wallace, LJ | 1 |
| De Koning, HP; Dogruel, M; Rodgers, J; Sanderson, L; Thomas, SA | 1 |
| Al-Salabi, MI; Augustyns, K; Berg, M; Castagna, V; Cos, P; de Koning, HP; Degano, M; Giannese, F; Grellier, P; Haemers, A; Joossens, J; Kohl, L; Maes, L; Steyaert, J; Van der Veken, P; Versées, W | 1 |
1 review(s) available for pentamidine and adenosine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for pentamidine and adenosine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity.
Topics: Animals; Biological Transport; Kinetoplastida; Mice; Nucleoside Transport Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Tubercidin | 2019 |
C6-O-alkylated 7-deazainosine nucleoside analogues: Discovery of potent and selective anti-sleeping sickness agents.
Topics: Alkylation; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Humans; Inosine; Molecular Structure; Nucleosides; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2020 |
Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei.
Topics: Adenosine; Animals; Arsenicals; Biological Transport; Carrier Proteins; Drug Resistance; Kinetics; Pentamidine; Species Specificity; Structure-Activity Relationship; Trypanosoma brucei brucei | 1995 |
In vitro assessment of susceptibility of Acanthamoeba polyphaga to drugs using combined methods of dye-binding assay and uptake of radiolabelled adenosine.
Topics: Acanthamoeba; Adenosine; Amebicides; Animals; Antimalarials; Antiprotozoal Agents; Biological Transport; Carbon Radioisotopes; Cell Division; Dose-Response Relationship, Drug; Eosine Yellowish-(YS); Isotope Labeling; Pentamidine | 1994 |
Characterisation of pentamidine-resistant Trypanosoma brucei brucei.
Topics: Adenosine; Animals; Biological Transport, Active; Drug Resistance; Male; Mice; Pentamidine; Rats; Rats, Sprague-Dawley; Trypanosoma brucei brucei; Virulence | 1995 |
A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity.
Topics: Adenosine; Animals; Arsenicals; Biological Transport, Active; Carrier Proteins; Diminazene; Drug Resistance; Kinetics; Pentamidine; Receptors, Purinergic P2; Trypanocidal Agents; Trypanosoma | 1995 |
Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
Topics: Adenine; Adenosine; Animals; Arsenicals; Diminazene; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Female; Inosine; Melarsoprol; Mice; Pentamidine; Trypanocidal Agents; Trypanosoma brucei brucei | 1997 |
Enzyme immunoassay detection of Cryptosporidium parvum inhibition by sinefungin in sporozoite infected HCT-8 enterocytic cells.
Topics: Adenosine; Amebicides; Animals; Antiprotozoal Agents; Cell Line; Cryptosporidium parvum; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Parasite Egg Count; Paromomycin; Pentamidine; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs.
Topics: Adenosine; Amino Acid Motifs; Animals; Binding Sites; Biological Transport; Carrier Proteins; Membrane Transport Proteins; Nuclear Proteins; Pentamidine; Protozoan Proteins; Receptors, Purinergic P1; Trypanocidal Agents; Trypanosoma brucei brucei | 1999 |
Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter.
Topics: Adenosine; Animals; Biological Transport; Carrier Proteins; Drug Resistance; Membrane Proteins; Nucleoside Transport Proteins; Pentamidine; Rats; Trypanocidal Agents; Trypanosoma brucei brucei | 2001 |
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.
Topics: Adenine; Adenosine; Animals; Arsenicals; Benzamidines; Cell Death; Cell Division; Diminazene; Drug Resistance; Female; Gene Silencing; Hypoxanthine; Inhibitory Concentration 50; Inosine; Melarsoprol; Mice; Mutation; Nucleoside Transport Proteins; Pentamidine; Stilbamidines; Trypanosoma brucei brucei | 2003 |
Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein.
Topics: Adenine; Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Blood-Brain Barrier; Brain; Cerebrospinal Fluid; Disease Models, Animal; Drug Interactions; Eflornithine; Indomethacin; Male; Melarsoprol; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mice, Knockout; Multidrug Resistance-Associated Proteins; Nifurtimox; Pentamidine; Perfusion; Suramin; Trypanosoma brucei brucei; Trypanosomiasis, African | 2009 |
Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasis.
Topics: Adenosine; Animals; Antiprotozoal Agents; Carrier Proteins; Gene Knockdown Techniques; Melarsoprol; Mice; Models, Chemical; N-Glycosyl Hydrolases; Pentamidine; RNA, Small Interfering; Trypanosoma brucei brucei; Trypanosomiasis, African | 2010 |